Researchers in Australia have developed a new method for treating cancer, a New York Times article reports. The new method is designed to side step two major drawbacks of standard chemotherapy -- the treatment's lack of specificity and the fact that cancer cells often develop resistance.

This could be a major breakthrough development in cancer treatment. However, "cancer experts who were not involved with the research say it could be ineffective in humans."

Bert Vogelstein, a leading cancer researcher at Johns Hopkins University, called the method "a creative and promising line of research" but relayed that the odds of success are stacked against success. "Unfortunately, our track record shows that far less than 1 percent of our promising approaches actually make the grade in patients," Vogelstein stated.

To read the full article, click here: http://www.nytimes.com/2009/06/29/health/research/29drug.html?_r=1&hp